WebCytoReason 4,363 followers on LinkedIn. The First Cell-Centered Computational Model of Human Disease CytoReason is a tech company developing a computational model of the human body. The company collects proprietary data from pharma companies and uses it to simulate human diseases – tissue by tissue, cell by cell. With CytoReason’s massive … Web1 day ago · CYTO stock is up 64.4% during pre-market trading on Wednesday! There’s more stock market news traders will want to read about below! InvestorPlace has all of …
Rebecca Bendayan, Ph.D. - Principal Scientist - LinkedIn
WebCytoReason Tel Aviv University About Dr. Rafael Torgovicky is an internationally recognized physician-entrepreneur, executive and investor, with over 20 years of clinical and industry... WebThe Strategy: Our “indication prioritization” component of the platform assesses multiple indications against a therapeutic hypothesis and predicts in which indication a given drug is most likely to be relevant. We define different criteria and test them within our pool of disease models. Defining the criteria is a critical step for ... highland optometrics
CytoReason LinkedIn
WebCytoReason’s AI machine learning algorithms integrate big data and deep data to simulate the expensive, slow, and risky drug discovery and development business cycles for … WebIndependent bioinformatics researcher, self-taught people-person. Experienced in data analysis and presentation using R, Python and a … WebI combine my background in biostatistics, health informatics and behavioral science to support organizations in the design, implementation and evaluation of behavioral change and health related projects. I am passionate about using a scientific approach to solve real-world challenges. Designing, prototyping and testing solutions is key to drive … highland opticians